RNA

Menghan Yang1, Fan Yu2, Hui Qin1

  • 1Department of Hematology, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

PubMed
概括

这项研究开发了多发性骨髓瘤 (MM) 预后的七基因风险评分,并确定了CD4+T细胞作为MM进展的关键参与者,帮助个性化治疗策略.